Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy

Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and s...

January 9, 2019 | Wednesday | News
Ascentage Pharma announces new license with Unity Biotechnology

Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies...

January 9, 2019 | Wednesday | News
Ascensia declares global partnership with POCTech for CGM systems

Ascensia Diabetes Care announced it has entered into a global alliance with Zhejiang POCTech, Co., Ltd (POCTech), a deve...

January 9, 2019 | Wednesday | News
WuXi Biologics, CANbridge expand rare disease partnership

CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved m...

January 9, 2019 | Wednesday | News
New scheme in China supports local generics manufacturers: GlobalData

The Chinese State Medical Insurance Administration introduced a new procurement in a recent round of reforms pilot schem...

January 7, 2019 | Monday | Analysis
Adagene collaborates with NIH to discover novel CAR-T

Adagene, Inc., an innovative antibody discovery and engineering company, announced collaboration with Dr. Richard C...

January 7, 2019 | Monday | News
NUI Galway opens stem cell research lab in China

NUI Galway is expanding its international collaboration on high end medical research with a stem cell research centre in...

January 7, 2019 | Monday | News
Samsung Bioepis, 3SBio partner to expand biosimilar business in China

Samsung Bioepis Co., Ltd. has announced that its rapidly growing biosimilar business will expand into mainland China thr...

January 7, 2019 | Monday | News
Sandoz inks biosimilars commercialization deal with Gan & Lee Pharmaceutical

  Sandoz, recently announced that it has entered into an agreement with Gan & Lee Pharmaceutical to commerci...

January 6, 2019 | Sunday | News
OrigiMed finishes series B round for oncology precision medicine

OrigiMed  Co., Ltd., has formally announced the completion of its Series B financing. This round of financing is le...

January 4, 2019 | Friday | News
Ping An Good Doctor launches commercial operation of One-minute Clinics

China's leading one-stop healthcare ecosystem platform Ping An Health Medical Technology Company Limited has releas...

January 4, 2019 | Friday | News
Betta Pharma uses ProBioGen's technology for cancer treatment

ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announce...

January 3, 2019 | Thursday | News
Antengene Corp raises $120 million in Series B financing

Antengene, a Shanghai based clinical stage therapeutics company focused on oncology has announced that it has completed ...

January 3, 2019 | Thursday | News
Connect Biopharma completes $55 Million Series B Funding

Connect Biopharmaceuticals, a clinical-stage company that discovers and develops novel immune modulators for the treatme...

January 3, 2019 | Thursday | News
HJB team up with MabSpace Biosciences to create Transcenta Holding

HJB and MabSpace Biosciences (MabSpace) today announced that the two companies have entered into a definitive merge...

January 2, 2019 | Wednesday | News
NABCB gets recognition for occupational health and safety management systems

The National Accreditation Board for Certification Bodies (NABCB), India’s national accreditation body, has secure...

January 2, 2019 | Wednesday | News
Zai Lab Announces Launch of Optune in Hong Kong for Patients with Glioblastoma Multiforme

Zai Lab  today announced the launch of Optune (Tumor Treating Fields or TTFields) in Hong Kong ...

January 1, 2019 | Tuesday | News
BeiGene initiates clinical trial of Tislelizumab with cancer patients

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecul...

December 31, 2018 | Monday | News